SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.

MLA

Christensen, Dale J., et al. “SET Oncoprotein Overexpression in B-Cell Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma: A Predictor of Aggressive Disease and a New Treatment Target.” Blood, vol. 118, no. 15, Oct. 2011, pp. 4150–58. EBSCOhost, https://doi.org/10.1182/blood-2011-04-351072.

APA

Christensen, D. J., Youwei Chen, Oddo, J., Matta, K. M., Neil, J., Davis, E. D., Volkheimer, A. D., Lanasa, M. C., Friedman, D. R., Goodman, B. K., Gockerman, J. P., Diehl, L. F., de Castro, C. M., Moore, J. O., Vitek, M. P., & Weinberg, J. B. (2011). SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target. Blood, 118(15), 4150–4158. https://doi.org/10.1182/blood-2011-04-351072

Chicago

Christensen, Dale J., Youwei Chen, Jessica Oddo, Karen M. Matta, Jessica Neil, Evan D. Davis, Alicia D. Volkheimer, et al. 2011. “SET Oncoprotein Overexpression in B-Cell Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma: A Predictor of Aggressive Disease and a New Treatment Target.” Blood 118 (15): 4150–58. doi:10.1182/blood-2011-04-351072.